Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in China

International Journal of Epidemiology

Volumn 45, Issue 2, 2016, Pages 441-449

  Yu, Wenzhou ^a   Liu, Dawei ^a   Zheng, Jingshan ^a   Liu, Yanmin ^a   An, Zhijie ^a   Rodewald, Lance ^b   Zhang, Guomin ^a   Su, Qiru ^a   Li, Keli ^a   Xu, Disha ^a   Wang, Fuzhen ^a   Yuan, Ping ^a   Xia, Wei ^b   Ning, Guijun ^a   Zheng, Hui ^a   Chu, Yaozhu ^a   Cui, Jian ^a   Duan, Mengjuan ^a   Hao, Lixin ^a   Zhou, Yuqing ^a   Wu, Zhenhua ^a   Zhang, Xuan ^a   Cui, Fuqiang ^a   Li, Li ^a   Wang, Huaqing ^a   more..

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Coincidental death; Communication; Hepatitis B vaccination; Vaccine confidence

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B ANTIBODY;

CHILD HEALTH; HEALTH SURVEY; HEPATITIS; IMMUNIZATION; MASS MEDIA; MORTALITY; TELECOMMUNICATION; VACCINATION; VACCINE; VIRUS;

ARTICLE; CHILD DEATH; CHINA; FEMALE; HEPATITIS B; HUMAN; INFANT; INFECTION PREVENTION; MALE; NEWBORN; PRIORITY JOURNAL; SOCIAL MEDIA; TELEPHONE INTERVIEW; TREATMENT REFUSAL; VACCINATION; ADVERSE DRUG REACTION; CAUSE OF DEATH; CHILD; DRUG SURVEILLANCE PROGRAM; EPIDEMIOLOGY; ETHNOLOGY; IMMUNOLOGY; MASS MEDIUM; MORTALITY; PREVENTIVE HEALTH SERVICE; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; TRENDS;

CHINA;

HEPATITIS B VIRUS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CAUSE OF DEATH; CHILD; CHINA; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT DEATH; INFANT, NEWBORN; MALE; MASS MEDIA; SURVEYS AND QUESTIONNAIRES; VACCINATION;

EID: 84971668405     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyv349     Document Type: Article

References (25)

1. Wang AL, Qiao YP, Wang LH, et al. Integrated prevention of mother-to-child transmission for human immunodeficiency virus, syphilis and hepatitis B virus in China. Bull World Health Organ 2015;93:52-56.
2. Evans AA, Chen G, Ross EA, et al. Eight-year follow-up of the 90, 000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prevepidemiology, biomarkers&prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(4):369-76.
3. Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009;27:6550-57.
4. Dai ZC, Qi GM. Seroepidemiological Survey in Chinese Population (Part One), 1992-1995. Beijing: Beijing Science and Technology Press, 1996.
5. Chen B, Zhang JM, Jiang Z, et al. (2015) Media and public reactions toward vaccination during the 'hepatitis B vaccine crisis' in China. Vaccine 33(15):1780-5 doi:10.1016/j.vaccine.2015.02.046.
6. Liu D, Wu W, Li K, et al. Surveillance of adverse events following immunization in China: Past, present, and future. Vaccine 2015;33:404146.
7. Ministry of Health of the People's Republic of China. Chinese Standard Procedures For Vaccination. Beijing: Ministry of Health, 2005.
8. Ministry of Health of the People's Republic of China. Guideline for the Identification of Adverse Reaction After Immunization. Beijing: Ministry of Health, 2008.
9. World Health Organization. Immunization Safety Surveillance: Guidelines for Managers of Immnunization Programmes on Reporting and Investigating Adverse Events Following Immunization (WPRO/EPI/99.01). Geneva: World Health Organization, 1999.
10. Li X, Wiesen E, Diorditsa S, et al. Impact of adverse events following immunization in Viet Nam in 2013 on chronic hepatitis B infection. Vaccine 2015. doi:10.1016/j.vaccine.2015.05.067.
11. Feng XL, Guo S, Hipgrave D, et al. China's facility-based birth strategy and neonatal mortality: a population-based epidemiological study. Lancet 2011;378:1493-500.
12. International Children's Emergency Fund. Infant Mortality Estimates. 2014. http://www.childmortality.org (16 September 2014, date last accessed).
13. Miller ER, Moro PL, Cano M, Shimabukuro TT. Deaths following vaccination: What does the evidence show? Vaccine 2015; 33(29):3288-92.
14. Moro PL, Arana J, Cano M, Lewis P, Shimabukuro TT. Deaths Reported to the Vaccine Adverse Event Reporting System, United States, 1997-2013. Clin Infect Dis 2015. doi:10.1093/cid/civ423.
15. Akehurst C. France suspends hepatitis B immunization for adolescents in schools. Euro Surveillance 1998; 2:1143.
16. World Health Organization. No Scientific Justification to Suspend Hepatitis B Immunization. Geneva: WHO, 1998.
17. Brown KF, Long SJ, Ramsay M, et al. U.K. parents' decisionmaking about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: a qualitative analysis. Vaccine 2012;30:1855-64.
18. Casiday R. Uncertainty, decision-making and trust: lessons from the MMR controversy. Community Pract 2006;79: 354-57.
19. Casiday R, Cresswell T, Wilson D, Panter-Brick C. A survey of UK parental attitudes to the MMR vaccine and trust in medical authority. Vaccine 2006;24:177-84.
20. Godlee F. Institutional research misconduct. BMJ 2011;343: d7284.
21. Simone B, Balasegaram S, Gobin M, et al. (2014) Evaluation of the measles, mumps and rubella vaccination catch-up campaign in England in 2013. Vaccine 2014;32:4681-88.
22. Fiebelkorn AP, Redd SB, Gallagher K, et al. Measles in the United States during the postelimination era. J Infect Dis 2010; 202:1520-28
23. Kaufmann JR, Feldbaum H. Diplomacy and the polio immunization boycott in Northern Nigeria. Health Aff 2009;28: 1091-101.
24. Larson HJ, Ghinai I. Lessons from polio eradication. Nature 2011;473:446-47.
25. Khetsuriani N, Imnadze P, Baidoshvili L, et al. (2010) Impact of unfounded vaccine safety concerns on the nationwide measlesrubella immunization campaign, Georgia, 2008. Vaccine 2011; 28:6455-62.